Abstract
The aim of this study was to determine if renin inhibition is able to improve the survival of transplanted stem cells in a mouse model of myocardial infarction. Myocardial infarction was induced in FVB/NJ inbred mice (n = 23). Bone marrow-derived mouse mesenchymal stromal cells (mMSCs, 3 × 105) expressing the reporter gene firefly luciferase were delivered intramyocardially (n = 12) and monitored non-invasively by bioluminescence imaging. A group of these mice (n = 6) received aliskiren (15 mg/kg/day) via an osmotic pump implanted subcutaneously. The survival of mMSCs was significantly increased in those animals that received aliskiren leading to a significant improvement in systolic function after myocardial infarction. Histological analysis revealed a significant reduction in inflammation and collagen deposition in those mice that received aliskiren compared to controls. Renin inhibition of the ischemic myocardium is able to modulate the microenvironment improving the survival and efficacy of transplanted mMSCs in a mouse model of myocardial infarction.
Similar content being viewed by others
References
Gersh, B. J., Simari, R. D., Behfar, A., Terzic, C. M., & Terzic, A. (2011). Cardiac cell repair therapy: a clinical perspective. Mayo Clinic Proceedings, 84(10), 876–892. doi:10.4065/84.10.876.
Assmus, B., Honold, J., Schächinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. The New England Journal of Medicine, 355(12), 1222–1232. doi:10.1056/NEJMoa051779.
Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine, 355(12), 1210–1221. doi:10.1056/NEJMoa060186.
Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., Desmet, W., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet, 367(9505), 113–121. doi:10.1016/S0140-6736(05)67861-0.
van der Bogt, K. E. A., Sheikh, A. Y., Schrepfer, S., Hoyt, G., Cao, F., Ransohoff, K. J., et al. (2008). Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation, 118(14_suppl_1), S121–S129. doi:10.1161/CIRCULATIONAHA.107.759480.
Mazo, M., Araña, M., Pelacho, B., & Prósper, F. (2012). Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells International, 2012, 1–11. doi:10.1155/2012/175979.
van der Bogt, K. E. A., Schrepfer, S., Yu, J., Sheikh, A. Y., Hoyt, G., Govaert, J. A., et al. (2009). Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation, 87(5), 642–652. doi:10.1097/TP.0b013e31819609d9.
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., et al. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine, 9(9), 1195–1201. doi:10.1038/nm912.
Mishra, P. K. (2008). Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation? Journal of Cardiovascular Medicine (Hagerstown, Md.), 9(2), 122–128. doi:10.2459/JCM.0b013e32820588f0.
Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54(24), 2277–2286. doi:10.1016/j.jacc.2009.06.055.
Chen, S.-l., Fang, W.-w., Ye, F., Liu, Y.-H., Qian, J., Shan, S.-j., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94(1), 92–95. doi:10.1016/j.amjcard.2004.03.034.
Forrester, J. S., Makkar, R. R., & Marban, E. (2009). Long-term outcome of stem cell therapy for acute myocardial infarction: right results, wrong reasons. Journal of the American College of Cardiology, 53(24), 2270–2272. doi:10.1016/j.jacc.2009.03.023.
Psaltis, P. J. M. P., Peterson, K. M. B., Xu, R. M., Franchi, F. P., Witt, T. C., Chen, I. Y. M. P., et al. (2013). Noninvasive monitoring of oxidative stress in transplanted mesenchymal stromal cells. Journal of the American College of Cardiology: Cardiovascular Imaging, 6(7), 795–802. doi:10.1016/j.jcmg.2012.11.018.
Frangogiannis, N. G. (2012). Regulation of the inflammatory response in cardiac repair. Circulation Research, 110(1), 159–173. doi:10.1161/CIRCRESAHA.111.243162.
Perlini, S., Salinaro, F., & Fonte, M. L. (2008). Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling? Hypertension, 52(6), 1019–1021. doi:10.1161/HYPERTENSIONAHA.108.121590.
Westermann, D., Riad, A., Lettau, O., Roks, A., Savvatis, K., Becher, P. M., et al. (2008). Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure. Hypertension, 52(6), 1068–1075. doi:10.1161/HYPERTENSIONAHA.108.116350.
Solomon, S. D., Shin, S. H., Shah, A., Skali, H., Desai, A., Kober, L., et al. (2011). Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. European Heart Journal, 32(10), 1227–1234. doi:10.1093/eurheartj/ehq522.
Soleimani, M., & Nadri, S. (2009). A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nature Protocols, 4(1), 102–106. doi:10.1038/nprot.2008.221.
Peterson, K. M., Aly, A., Lerman, A., Lerman, L. O., & Rodriguez-Porcel, M. (2011). Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Life Sciences, 88(1–2), 65–73. doi:10.1016/j.lfs.2010.10.023.
Rodriguez-Porcel, M., Gheysens, O., Paulmurugan, R., Chen, I. Y., Peterson, K. M., Willmann, J. K., et al. (2010). Antioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium. Molecular Imaging and Biology: The Official Publication of the Academy of Molecular Imaging, 12(3), 325–334. doi:10.1007/s11307-009-0274-4.
Wang, X., Zhao, T., Huang, W., Wang, T., Qian, J., Xu, M., et al. (2009). Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells, 27(12), 3021–3031. doi:10.1002/stem.230.
Tsubokawa, T., Yagi, K., Nakanishi, C., Zuka, M., Nohara, A., Ino, H., et al. (2010). Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. American Journal of Physiology. Heart and Circulatory Physiology, 298(5), H1320–H1329. doi:10.1152/ajpheart.01330.2008.
Rodriguez-Porcel, M., Gheysens, O., Chen, I. Y., Wu, J. C., & Gambhir, S. S. (2005). Image-guided cardiac cell delivery using high-resolution small-animal ultrasound. Molecular Therapy: The Journal of the American Society of Gene Therapy, 12(6), 1142–1147. doi:10.1016/j.ymthe.2005.07.532.
Wu, J. C. (2003). Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation, 108(11), 1302–1305. doi:10.1161/01.CIR.0000091252.20010.6E.
Psaltis, P. J., Simari, R. D., & Rodriguez-Porcel, M. (2011). Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging, 39(1), 165–181. doi:10.1007/s00259-011-1925-7.
Dai, W., Hale, S. L., Martin, B. J., Kuang, J. Q., Dow, J. S., Wold, L. E., et al. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation, 112(2), 214–223. doi:10.1161/CIRCULATIONAHA.104.527937.
Amsalem, Y., Mardor, Y., Feinberg, M. S., Landa, N., Miller, L., Daniels, D., et al. (2007). Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation, 116(11 Suppl), I38–I45. doi:10.1161/CIRCULATIONAHA.106.680231.
Poss, J., Werner, C., Lorenz, D., Gensch, C., Bohm, M., & Laufs, U. (2010). The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice. Basic Research in Cardiology, 105(6), 725–735. doi:10.1007/s00395-010-0120-5.
Singh, V. P., Le, B., Khode, R., Baker, K. M., & Kumar, R. (2008). Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes, 57(12), 3297–3306. doi:10.2337/db08-0805.
Acknowledgments
The authors would like to acknowledge Mr. Bruce Knudsen for his assistance with the non-invasive measurement of blood pressure and Mrs. Elise Oheler for her assistance with the high-resolution ultrasonography.
Conflict of Interest
None declared.
No human studies were carried out by the authors for this article.
All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees
Sources of Funding
Novartis and the Mayo Foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Enrique Lara-Pezzi oversaw the review of this article
Rights and permissions
About this article
Cite this article
Franchi, F., Ezenekwe, A., Wellkamp, L. et al. Renin Inhibition Improves the Survival of Mesenchymal Stromal Cells in a Mouse Model of Myocardial Infarction. J. of Cardiovasc. Trans. Res. 7, 560–569 (2014). https://doi.org/10.1007/s12265-014-9575-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-014-9575-3